Found: 15
Select item for more details and to access through your institution.
SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 12, p. 7591, doi. 10.1093/nar/gku451
- By:
- Publication type:
- Article
Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 599, doi. 10.1111/bjh.17246
- By:
- Publication type:
- Article
Application of the LymphGen classification tool to 928 clinically and genetically‐characterised cases of diffuse large B cell lymphoma (DLBCL).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 1, p. 216, doi. 10.1111/bjh.17132
- By:
- Publication type:
- Article
Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 781, doi. 10.1111/bjh.15619
- By:
- Publication type:
- Article
Cryptic 5q deletion in a patient with myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 347, doi. 10.1111/bjh.14590
- By:
- Publication type:
- Article
Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 4, p. 441, doi. 10.1111/bjh.12045
- By:
- Publication type:
- Article
The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit.
- Published in:
- Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 125, doi. 10.1002/cjp2.10
- By:
- Publication type:
- Article
A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055895
- By:
- Publication type:
- Article
t(3;14)(p14;q32) Results in aberrant expression of FOXP1 in a case of diffuse large B‐cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2006, v. 45, n. 2, p. 164, doi. 10.1002/gcc.20278
- By:
- Publication type:
- Article
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trial.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.3
- By:
- Publication type:
- Article
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas.
- Published in:
- Genome Medicine, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13073-015-0187-6
- By:
- Publication type:
- Article
Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 2, p. 322, doi. 10.1046/j.1365-2141.2002.03435.x
- By:
- Publication type:
- Article
Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression.
- Published in:
- British Journal of Haematology, 1999, v. 104, n. 1, p. 138, doi. 10.1046/j.1365-2141.1999.01134.x
- By:
- Publication type:
- Article
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01437-0
- By:
- Publication type:
- Article